“Forget the price. What’s the value of that treatment?”
What if we could fix a patient’s own cells and cure their disease once and for all instead of treating a chronic illness over their lifetime? The solution exists, but it’s expensive. Nick Leschly, chief bluebird, explains how biotechnology can deliver corrective genes into a patient’s diseased cells and disrupt the medical and insurance industries along the way.